BIORESTORATIVE THERAPIES, INC. Debt Securities, Available-for-sale, Amortized Cost
BIORESTORATIVE THERAPIES, INC. (BRTX) had Debt Securities, Available-for-sale, Amortized Cost of $475.44 thousand as of 2026-03-31, per its 10-Q filed 2026-05-14.
Financial Statements › Notes
us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis · last filed 2026-05-14
- 2026-03-31: Debt Securities, Available-for-sale, Amortized Cost $475.44K.
- 2025-12-31: Debt Securities, Available-for-sale, Amortized Cost $1.42M.
- 2024-12-31: Debt Securities, Available-for-sale, Amortized Cost $9.98M.
| Period end | Debt Securities, Available-for-sale, Amortized Cost |
|---|---|
| 2026-03-31 | $475.44K 10-Q · filed 2026-05-14 |
| 2025-12-31 | $1.42M 10-Q · filed 2026-05-14 |
| 2024-12-31 | $9.98M 10-K · filed 2026-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |